APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bispecific and Multispecific Antibody Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Bispecific and Multispecific Antibody Service Market Analysis and Forecast 2026-2032

Report ID 174079780216 April 2026186 pages

Choose your research edition.

Industry ResearchBispecific and Multispecific Antibody Service Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Bispecific and Multispecific Antibody Service Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Bispecific and Multispecific Antibody Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bispecific and Multispecific Antibody Service Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Bispecific and Multispecific Antibody Service Market Analysis and Forecast 2026-2032186 pages · $4,950 USD

Market perspective

The global Bispecific and Multispecific Antibody Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Bispecific and Multispecific Antibody Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Bispecific and Multispecific Antibody Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Bispecific and Multispecific Antibody Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Bispecific and Multispecific Antibody Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Bispecific and Multispecific Antibody Service include evitria, WuXi Biologics, Sino Biological, Alloy Therapeutics, Biointron, Akeso, Inc, Absolute Antibody, Zymeworks and Genedata Biologics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Bispecific and Multispecific Antibody Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Bispecific and Multispecific Antibody Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Bispecific and Multispecific Antibody Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Bispecific and Multispecific Antibody Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Bispecific and Multispecific Antibody Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Bispecific and Multispecific Antibody Service revenue, projected growth trends, production technology, application and end-user industry.

Bispecific and Multispecific Antibody Service Segment by Company

evitria

WuXi Biologics

Sino Biological

Alloy Therapeutics

Biointron

Akeso, Inc

Absolute Antibody

Zymeworks

Genedata Biologics

Creative Biolabs

ACROBiosystems

Invenra

ProteoGenix

Bispecific and Multispecific Antibody Service Segment by Type

Biochemical Characterization Service

Structural Characterization Service

Functional Characterization Service

Others

Bispecific and Multispecific Antibody Service Segment by Application

Cancer Treatment

Autoimmune Diseases

Infectious Diseases

Others

Bispecific and Multispecific Antibody Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bispecific and Multispecific Antibody Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bispecific and Multispecific Antibody Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bispecific and Multispecific Antibody Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Bispecific and Multispecific Antibody Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Bispecific and Multispecific Antibody Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bispecific and Multispecific Antibody Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Bispecific and Multispecific Antibody Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biochemical Characterization Service Major Player Table 3. Structural Characterization Service Major Player Table 4. Functional Characterization Service Major Player Table 5. Others Major Player Table 6. Global Bispecific and Multispecific Antibody Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Cancer Treatment Major Player Table 8. Autoimmune Diseases Major Player Table 9. Infectious Diseases Major Player Table 10. Others Major Player Table 11. Bispecific and Multispecific Antibody Service Industry Trends Table 12. Bispecific and Multispecific Antibody Service Industry Drivers Table 13. Bispecific and Multispecific Antibody Service Industry Opportunities and Challenges Table 14. Bispecific and Multispecific Antibody Service Industry Restraints Table 15. Global Bispecific and Multispecific Antibody Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Bispecific and Multispecific Antibody Service Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Bispecific and Multispecific Antibody Service Market Share by Region (2021-2026) Table 18. Global Bispecific and Multispecific Antibody Service Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Bispecific and Multispecific Antibody Service Market Share by Region (2027-2032) Table 20. Global Bispecific and Multispecific Antibody Service Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Bispecific and Multispecific Antibody Service Revenue Market Share by Players (2021-2026) Table 22. Global Bispecific and Multispecific Antibody Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Bispecific and Multispecific Antibody Service Key Players Headquarters & Area Served Table 24. Global Bispecific and Multispecific Antibody Service Players, Product Type & Application Table 25. Global Bispecific and Multispecific Antibody Service Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Bispecific and Multispecific Antibody Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Bispecific and Multispecific Antibody Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Bispecific and Multispecific Antibody Service Revenue Market Share by Type (2021-2026) Table 32. Global Bispecific and Multispecific Antibody Service Revenue Market Share by Type (2027-2032) Table 33. Global Bispecific and Multispecific Antibody Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Bispecific and Multispecific Antibody Service Revenue Market Share by Application (2021-2026) Table 37. Global Bispecific and Multispecific Antibody Service Revenue Market Share by Application (2027-2032) Table 38. evitria Company Information Table 39. evitria Business Overview Table 40. evitria Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. evitria Bispecific and Multispecific Antibody Service Product Portfolio Table 42. evitria Recent Development Table 43. WuXi Biologics Company Information Table 44. WuXi Biologics Business Overview Table 45. WuXi Biologics Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. WuXi Biologics Bispecific and Multispecific Antibody Service Product Portfolio Table 47. WuXi Biologics Recent Development Table 48. Sino Biological Company Information Table 49. Sino Biological Business Overview Table 50. Sino Biological Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Sino Biological Bispecific and Multispecific Antibody Service Product Portfolio Table 52. Sino Biological Recent Development Table 53. Alloy Therapeutics Company Information Table 54. Alloy Therapeutics Business Overview Table 55. Alloy Therapeutics Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Alloy Therapeutics Bispecific and Multispecific Antibody Service Product Portfolio Table 57. Alloy Therapeutics Recent Development Table 58. Biointron Company Information Table 59. Biointron Business Overview Table 60. Biointron Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Biointron Bispecific and Multispecific Antibody Service Product Portfolio Table 62. Biointron Recent Development Table 63. Akeso, Inc Company Information Table 64. Akeso, Inc Business Overview Table 65. Akeso, Inc Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Akeso, Inc Bispecific and Multispecific Antibody Service Product Portfolio Table 67. Akeso, Inc Recent Development Table 68. Absolute Antibody Company Information Table 69. Absolute Antibody Business Overview Table 70. Absolute Antibody Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Absolute Antibody Bispecific and Multispecific Antibody Service Product Portfolio Table 72. Absolute Antibody Recent Development Table 73. Zymeworks Company Information Table 74. Zymeworks Business Overview Table 75. Zymeworks Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Zymeworks Bispecific and Multispecific Antibody Service Product Portfolio Table 77. Zymeworks Recent Development Table 78. Genedata Biologics Company Information Table 79. Genedata Biologics Business Overview Table 80. Genedata Biologics Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Genedata Biologics Bispecific and Multispecific Antibody Service Product Portfolio Table 82. Genedata Biologics Recent Development Table 83. Creative Biolabs Company Information Table 84. Creative Biolabs Business Overview Table 85. Creative Biolabs Bispecific and Multispecific Antibody Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Creative Biolabs Bispecific and Multispecific Antibody Service Product Portfolio Table 87. Creative Biolabs Recent Development Table 88. ACROBiosystems Company Information Table 89. ACROBiosystems Business Overview Table 90. ACROBiosystems Bispecific and Multispecific Antibody Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. ACROBiosystems Bispecific and Multispecific Antibody Service Product Portfolio Table 92. ACROBiosystems Recent Development Table 93. Invenra Company Information Table 94. Invenra Business Overview Table 95. Invenra Bispecific and Multispecific Antibody Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Invenra Bispecific and Multispecific Antibody Service Product Portfolio Table 97. Invenra Recent Development Table 98. ProteoGenix Company Information Table 99. ProteoGenix Business Overview Table 100. ProteoGenix Bispecific and Multispecific Antibody Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. ProteoGenix Bispecific and Multispecific Antibody Service Product Portfolio Table 102. ProteoGenix Recent Development Table 103. North America Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026) & (US$ Million) Table 106. North America Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032) & (US$ Million) Table 107. North America Bispecific and Multispecific Antibody Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Bispecific and Multispecific Antibody Service Revenue by Country (2021-2026) & (US$ Million) Table 109. North America Bispecific and Multispecific Antibody Service Revenue by Country (US$ Million) & (2027-2032) Table 110. Europe Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026) & (US$ Million) Table 113. Europe Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032) & (US$ Million) Table 114. Europe Bispecific and Multispecific Antibody Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. Europe Bispecific and Multispecific Antibody Service Revenue by Country (2021-2026) & (US$ Million) Table 116. Europe Bispecific and Multispecific Antibody Service Revenue by Country (US$ Million) & (2027-2032) Table 117. China Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026) & (US$ Million) Table 118. China Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032) & (US$ Million) Table 119. China Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026) & (US$ Million) Table 120. China Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026) & (US$ Million) Table 122. Asia Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032) & (US$ Million) Table 123. Asia Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026) & (US$ Million) Table 124. Asia Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Bispecific and Multispecific Antibody Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 126. Asia Bispecific and Multispecific Antibody Service Revenue by Region (US$ Million) & (2021-2026) Table 127. Asia Bispecific and Multispecific Antibody Service Revenue by Region (US$ Million) & (2027-2032) Table 128. SAMEA Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026) & (US$ Million) Table 129. SAMEA Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032) & (US$ Million) Table 130. SAMEA Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026) & (US$ Million) Table 131. SAMEA Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032) & (US$ Million) Table 132. SAMEA Bispecific and Multispecific Antibody Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. SAMEA Bispecific and Multispecific Antibody Service Revenue by Country (2021-2026) & (US$ Million) Table 134. SAMEA Bispecific and Multispecific Antibody Service Revenue by Country (US$ Million) & (2027-2032) Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Bispecific and Multispecific Antibody Service Image Figure 2. Global Bispecific and Multispecific Antibody Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bispecific and Multispecific Antibody Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biochemical Characterization Service Image Figure 5. Structural Characterization Service Image Figure 6. Functional Characterization Service Image Figure 7. Others Image Figure 8. Global Bispecific and Multispecific Antibody Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Bispecific and Multispecific Antibody Service Market Size Share 2021 VS 2025 VS 2032 Figure 10. Cancer Treatment Image Figure 11. Autoimmune Diseases Image Figure 12. Infectious Diseases Image Figure 13. Others Image Figure 14. Global Bispecific and Multispecific Antibody Service Market Size (US$ Million) & (2021-2032) Figure 15. Global Bispecific and Multispecific Antibody Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Bispecific and Multispecific Antibody Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Bispecific and Multispecific Antibody Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Bispecific and Multispecific Antibody Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Bispecific and Multispecific Antibody Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Bispecific and Multispecific Antibody Service Revenue Market Share by Type (2021-2032) Figure 22. Global Bispecific and Multispecific Antibody Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Bispecific and Multispecific Antibody Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Bispecific and Multispecific Antibody Service Revenue Market Share by Application (2021-2032) Figure 25. North America Bispecific and Multispecific Antibody Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032) Figure 27. North America Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032) Figure 28. North America Bispecific and Multispecific Antibody Service Revenue Share by Country (2021-2032) Figure 29. United States Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Bispecific and Multispecific Antibody Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032) Figure 34. Europe Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032) Figure 35. Europe Bispecific and Multispecific Antibody Service Revenue Share by Country (2021-2032) Figure 36. Germany Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Bispecific and Multispecific Antibody Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032) Figure 46. China Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032) Figure 47. Asia Bispecific and Multispecific Antibody Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032) Figure 49. Asia Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032) Figure 50. Asia Bispecific and Multispecific Antibody Service Revenue Share by Region (2021-2032) Figure 51. Japan Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Bispecific and Multispecific Antibody Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032) Figure 59. SAMEA Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032) Figure 60. SAMEA Bispecific and Multispecific Antibody Service Revenue Share by Country (2021-2032) Figure 61. Brazil Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Bispecific and Multispecific Antibody Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Biochemical Characterization Service
  • Structural Characterization Service
  • Functional Characterization Service
  • Others
Applications
  • Cancer Treatment
  • Autoimmune Diseases
  • Infectious Diseases
  • Others
Companies covered
  • evitria
  • WuXi Biologics
  • Sino Biological
  • Alloy Therapeutics
  • Biointron
  • Akeso, Inc
  • Absolute Antibody
  • Zymeworks
  • Genedata Biologics
  • Creative Biolabs
  • ACROBiosystems
  • Invenra
  • ProteoGenix

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Bispecific and Multispecific Antibody Service Market by Type
  3. 1.2.1 Global Bispecific and Multispecific Antibody Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biochemical Characterization Service
  5. 1.2.3 Structural Characterization Service
  6. 1.2.4 Functional Characterization Service
  7. 1.2.5 Others
  8. 1.3 Bispecific and Multispecific Antibody Service Market by Application
  9. 1.3.1 Global Bispecific and Multispecific Antibody Service Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Cancer Treatment
  11. 1.3.3 Autoimmune Diseases
  12. 1.3.4 Infectious Diseases
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Bispecific and Multispecific Antibody Service Market Dynamics
  1. 2.1 Bispecific and Multispecific Antibody Service Industry Trends
  2. 2.2 Bispecific and Multispecific Antibody Service Industry Drivers
  3. 2.3 Bispecific and Multispecific Antibody Service Industry Opportunities and Challenges
  4. 2.4 Bispecific and Multispecific Antibody Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Bispecific and Multispecific Antibody Service Market Perspective (2021-2032)
  2. 3.2 Global Bispecific and Multispecific Antibody Service Growth Trends by Region
  3. 3.2.1 Global Bispecific and Multispecific Antibody Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Bispecific and Multispecific Antibody Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Bispecific and Multispecific Antibody Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Bispecific and Multispecific Antibody Service Revenue by Players
  2. 4.1.1 Global Bispecific and Multispecific Antibody Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Bispecific and Multispecific Antibody Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Bispecific and Multispecific Antibody Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Bispecific and Multispecific Antibody Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Bispecific and Multispecific Antibody Service Key Players Headquarters & Area Served
  7. 4.4 Global Bispecific and Multispecific Antibody Service Players, Product Type & Application
  8. 4.5 Global Bispecific and Multispecific Antibody Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Bispecific and Multispecific Antibody Service Market CR5 and HHI
  11. 4.6.3 2025 Bispecific and Multispecific Antibody Service Tier 1, Tier 2, and Tier 3
5 Bispecific and Multispecific Antibody Service Market Size by Type
  1. 5.1 Global Bispecific and Multispecific Antibody Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Bispecific and Multispecific Antibody Service Revenue by Type (2021-2032)
  3. 5.3 Global Bispecific and Multispecific Antibody Service Revenue Market Share by Type (2021-2032)
6 Bispecific and Multispecific Antibody Service Market Size by Application
  1. 6.1 Global Bispecific and Multispecific Antibody Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Bispecific and Multispecific Antibody Service Revenue by Application (2021-2032)
  3. 6.3 Global Bispecific and Multispecific Antibody Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 evitria
  2. 7.1.1 evitria Company Information
  3. 7.1.2 evitria Business Overview
  4. 7.1.3 evitria Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 evitria Bispecific and Multispecific Antibody Service Product Portfolio
  6. 7.1.5 evitria Recent Developments
  7. 7.2 WuXi Biologics
  8. 7.2.1 WuXi Biologics Company Information
  9. 7.2.2 WuXi Biologics Business Overview
  10. 7.2.3 WuXi Biologics Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 WuXi Biologics Bispecific and Multispecific Antibody Service Product Portfolio
  12. 7.2.5 WuXi Biologics Recent Developments
  13. 7.3 Sino Biological
  14. 7.3.1 Sino Biological Company Information
  15. 7.3.2 Sino Biological Business Overview
  16. 7.3.3 Sino Biological Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Sino Biological Bispecific and Multispecific Antibody Service Product Portfolio
  18. 7.3.5 Sino Biological Recent Developments
  19. 7.4 Alloy Therapeutics
  20. 7.4.1 Alloy Therapeutics Company Information
  21. 7.4.2 Alloy Therapeutics Business Overview
  22. 7.4.3 Alloy Therapeutics Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Alloy Therapeutics Bispecific and Multispecific Antibody Service Product Portfolio
  24. 7.4.5 Alloy Therapeutics Recent Developments
  25. 7.5 Biointron
  26. 7.5.1 Biointron Company Information
  27. 7.5.2 Biointron Business Overview
  28. 7.5.3 Biointron Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Biointron Bispecific and Multispecific Antibody Service Product Portfolio
  30. 7.5.5 Biointron Recent Developments
  31. 7.6 Akeso, Inc
  32. 7.6.1 Akeso, Inc Company Information
  33. 7.6.2 Akeso, Inc Business Overview
  34. 7.6.3 Akeso, Inc Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Akeso, Inc Bispecific and Multispecific Antibody Service Product Portfolio
  36. 7.6.5 Akeso, Inc Recent Developments
  37. 7.7 Absolute Antibody
  38. 7.7.1 Absolute Antibody Company Information
  39. 7.7.2 Absolute Antibody Business Overview
  40. 7.7.3 Absolute Antibody Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Absolute Antibody Bispecific and Multispecific Antibody Service Product Portfolio
  42. 7.7.5 Absolute Antibody Recent Developments
  43. 7.8 Zymeworks
  44. 7.8.1 Zymeworks Company Information
  45. 7.8.2 Zymeworks Business Overview
  46. 7.8.3 Zymeworks Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Zymeworks Bispecific and Multispecific Antibody Service Product Portfolio
  48. 7.8.5 Zymeworks Recent Developments
  49. 7.9 Genedata Biologics
  50. 7.9.1 Genedata Biologics Company Information
  51. 7.9.2 Genedata Biologics Business Overview
  52. 7.9.3 Genedata Biologics Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Genedata Biologics Bispecific and Multispecific Antibody Service Product Portfolio
  54. 7.9.5 Genedata Biologics Recent Developments
  55. 7.10 Creative Biolabs
  56. 7.10.1 Creative Biolabs Company Information
  57. 7.10.2 Creative Biolabs Business Overview
  58. 7.10.3 Creative Biolabs Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Creative Biolabs Bispecific and Multispecific Antibody Service Product Portfolio
  60. 7.10.5 Creative Biolabs Recent Developments
  61. 7.11 ACROBiosystems
  62. 7.11.1 ACROBiosystems Company Information
  63. 7.11.2 ACROBiosystems Business Overview
  64. 7.11.3 ACROBiosystems Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ACROBiosystems Bispecific and Multispecific Antibody Service Product Portfolio
  66. 7.11.5 ACROBiosystems Recent Developments
  67. 7.12 Invenra
  68. 7.12.1 Invenra Company Information
  69. 7.12.2 Invenra Business Overview
  70. 7.12.3 Invenra Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Invenra Bispecific and Multispecific Antibody Service Product Portfolio
  72. 7.12.5 Invenra Recent Developments
  73. 7.13 ProteoGenix
  74. 7.13.1 ProteoGenix Company Information
  75. 7.13.2 ProteoGenix Business Overview
  76. 7.13.3 ProteoGenix Bispecific and Multispecific Antibody Service Revenue and Gross Margin (2021-2026)
  77. 7.13.4 ProteoGenix Bispecific and Multispecific Antibody Service Product Portfolio
  78. 7.13.5 ProteoGenix Recent Developments
8 North America
  1. 8.1 North America Bispecific and Multispecific Antibody Service Revenue (2021-2032)
  2. 8.2 North America Bispecific and Multispecific Antibody Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032)
  5. 8.3 North America Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Bispecific and Multispecific Antibody Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032)
  9. 8.5 North America Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Bispecific and Multispecific Antibody Service Revenue by Country
  11. 8.6.1 North America Bispecific and Multispecific Antibody Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Bispecific and Multispecific Antibody Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Bispecific and Multispecific Antibody Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Bispecific and Multispecific Antibody Service Revenue (2021-2032)
  2. 9.2 Europe Bispecific and Multispecific Antibody Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032)
  5. 9.3 Europe Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Bispecific and Multispecific Antibody Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032)
  9. 9.5 Europe Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Bispecific and Multispecific Antibody Service Revenue by Country
  11. 9.6.1 Europe Bispecific and Multispecific Antibody Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Bispecific and Multispecific Antibody Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Bispecific and Multispecific Antibody Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Bispecific and Multispecific Antibody Service Revenue (2021-2032)
  2. 10.2 China Bispecific and Multispecific Antibody Service Revenue by Type (2021-2032)
  3. 10.2.1 China Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026)
  4. 10.2.2 China Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032)
  5. 10.3 China Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032)
  6. 10.4 China Bispecific and Multispecific Antibody Service Revenue by Application (2021-2032)
  7. 10.4.1 China Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026)
  8. 10.4.2 China Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032)
  9. 10.5 China Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Bispecific and Multispecific Antibody Service Revenue (2021-2032)
  2. 11.2 Asia Bispecific and Multispecific Antibody Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032)
  5. 11.3 Asia Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Bispecific and Multispecific Antibody Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032)
  9. 11.5 Asia Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Bispecific and Multispecific Antibody Service Revenue by Country
  11. 11.6.1 Asia Bispecific and Multispecific Antibody Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Bispecific and Multispecific Antibody Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Bispecific and Multispecific Antibody Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Bispecific and Multispecific Antibody Service Revenue (2021-2032)
  2. 12.2 SAMEA Bispecific and Multispecific Antibody Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Bispecific and Multispecific Antibody Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Bispecific and Multispecific Antibody Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Bispecific and Multispecific Antibody Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Bispecific and Multispecific Antibody Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Bispecific and Multispecific Antibody Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Bispecific and Multispecific Antibody Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Bispecific and Multispecific Antibody Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Bispecific and Multispecific Antibody Service Revenue by Country
  11. 12.6.1 SAMEA Bispecific and Multispecific Antibody Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Bispecific and Multispecific Antibody Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Bispecific and Multispecific Antibody Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst